Literature DB >> 24990889

Standardized mini-mental state examination scores and verbal memory performance at a memory center: implications for cognitive screening.

Maureen Lacy1, Tobias Kaemmerer2, Sheena Czipri2.   

Abstract

Memory decline is often among the first signs heralding the emergence of mild cognitive impairment or dementia regardless of etiology. Despite its limited inclusion of memory screening, the Mini-Mental State Exam (MMSE) continues to be the most ubiquitous, first-line screening tool for dementia and cognitive decline. In response to well documented problems with the sensitivity of this instrument and the growing importance of cognitive screening, we assessed the utility of the MMSE as a screening tool among older adults presenting for evaluation at a memory clinic. The Standardized MMSE and a standardized verbal memory test - the Hopkins Verbal Learning Test-Revised (HVLT-R) - were administered to 304 consecutive referrals at a university-based outpatient memory clinic. Among patients scoring above 25 on the MMSE (n = 169), over half exhibited at least moderate memory impairment (HVLT-R delayed recall z ≤ -2.0) and more than 25% showed severe impairment (delayed recall z ≤ -3.0). Perhaps even more striking was that among those who achieved perfect (30/30) or near perfect (29/30) scores on the MMSE (n = 70), 43% displayed moderate to severe memory impairment. Although newer screening measures have shown improved sensitivity, more in-depth memory testing appears to be a vital component of successful screening and early detection.
© The Author(s) 2014.

Entities:  

Keywords:  HVLT-R; MMSE; cognitive screening; dementia; mild cognitive impairment

Mesh:

Year:  2014        PMID: 24990889     DOI: 10.1177/1533317514539378

Source DB:  PubMed          Journal:  Am J Alzheimers Dis Other Demen        ISSN: 1533-3175            Impact factor:   2.035


  8 in total

1.  Assessing and preventing cognitive impairment in the elderly.

Authors:  Graham J McDougall, Jr
Journal:  Am Nurse Today       Date:  2017-11-20

2.  Pulsed radiation therapy for the treatment of newly diagnosed glioblastoma.

Authors:  Muayad F Almahariq; Thomas J Quinn; Jessica D Arden; P T Roskos; George D Wilson; Brian Marples; Inga S Grills; Peter Y Chen; Daniel J Krauss; Prakash Chinnaiyan; Joshua T Dilworth
Journal:  Neuro Oncol       Date:  2021-03-25       Impact factor: 12.300

3.  Cognitive function in a general population of men and women: a cross sectional study in the European Investigation of Cancer-Norfolk cohort (EPIC-Norfolk).

Authors:  Shabina A Hayat; Robert Luben; Stephanie Moore; Nichola Dalzell; Amit Bhaniani; Serena Anuj; Fiona E Matthews; Nick Wareham; Kay-Tee Khaw; Carol Brayne
Journal:  BMC Geriatr       Date:  2014-12-19       Impact factor: 3.921

4.  Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite score.

Authors:  Yen Ying Lim; Peter J Snyder; Robert H Pietrzak; Albulene Ukiqi; Victor L Villemagne; David Ames; Olivier Salvado; Pierrick Bourgeat; Ralph N Martins; Colin L Masters; Christopher C Rowe; Paul Maruff
Journal:  Alzheimers Dement (Amst)       Date:  2015-12-12

5.  Prediction of Fitness to Drive in Patients with Alzheimer's Dementia.

Authors:  Dafne Piersma; Anselm B M Fuermaier; Dick de Waard; Ragnhild J Davidse; Jolieke de Groot; Michelle J A Doumen; Ruud A Bredewoud; René Claesen; Afina W Lemstra; Annemiek Vermeeren; Rudolf Ponds; Frans Verhey; Wiebo H Brouwer; Oliver Tucha
Journal:  PLoS One       Date:  2016-02-24       Impact factor: 3.240

6.  Is comprehensiveness critical? Comparing short and long format cognitive assessments in preclinical Alzheimer disease.

Authors:  Jason Hassenstab; Jessica Nicosia; Megan LaRose; Andrew J Aschenbrenner; Brian A Gordon; Tammie L S Benzinger; Chengjie Xiong; John C Morris
Journal:  Alzheimers Res Ther       Date:  2021-09-13       Impact factor: 6.982

7.  The Correlations among Depressive Symptoms, Cognitive Performance and Serum BDNF Levels in the Patients with Chronic Kidney Disease.

Authors:  Jung Goo Lee; Min Kyung Park; Yeong Hoon Kim; Yang-Wook Kim; Kyubok Jin; Sung Woo Park; Mi Kyoung Seo; Young Hoon Kim
Journal:  Psychiatry Investig       Date:  2017-10-13       Impact factor: 2.505

8.  Blood Pressure Circadian Variation, Cognition and Brain Imaging in 90+ Year-Olds.

Authors:  Annlia Paganini-Hill; Natalie Bryant; Maria M Corrada; Dana E Greenia; Evan Fletcher; Baljeet Singh; David Floriolli; Claudia H Kawas; Mark J Fisher
Journal:  Front Aging Neurosci       Date:  2019-04-17       Impact factor: 5.750

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.